12:00 AM
 | 
Mar 26, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Illumigene Group B Streptococcus regulatory update

Meridian said Australia's Therapeutic Goods Administration ( TGA) approved illumigene Group B Streptococcus (GBS) test. The molecular...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >